CC BY 4.0 · TH Open 2019; 03(01): e10-e19
DOI: 10.1055/s-0038-1677030
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Endogenous Procoagulant Activity in Trauma Patients and Its Relationship to Trauma Severity

Shannon M. Prior
1   Department of Biochemistry, University of Vermont, Colchester, Vermont, United States
,
Myung S. Park
2   Division of Trauma, Critical Care, and General Surgery, Mayo Clinic, Rochester, Minnesota, United States
,
Kenneth G. Mann
1   Department of Biochemistry, University of Vermont, Colchester, Vermont, United States
,
Saulius Butenas
1   Department of Biochemistry, University of Vermont, Colchester, Vermont, United States
› Author Affiliations
Funding This work was supported by the National Institutes of Health (UM1 HL120877 TACTIC grant; S.B., M.S.P) and by the US Army Medical Research and Medical Command (AR 360–5; M.S.P.).
Further Information

Publication History

03 May 2018

27 November 2018

Publication Date:
07 January 2019 (online)

Abstract

Background It has been observed that trauma patients have elevated plasma procoagulant activity that could be assigned to an elevated concentration of tissue factor (TF). However, in many instances there is a discrepancy between the levels of TF and the procoagulant activity observed. We hypothesized that factor XIa (FXIa) could be responsible for this additional activity and that the presence and levels of both proteins could correlate with trauma severity.

Methods Citrate plasma from 98 trauma patients (47 blunt, 17 penetrating, and 34 thermal) were evaluated in clotting assays for the presence of FXIa and TF activity using respective inhibitory antibodies.

Results When the three trauma patient groups were divided into two cohorts (Injury Severity Score [ISS] > 25 and ISS ≤ 25), higher frequencies and concentrations of both TF and FXIa were observed for all the more severe injury subgroups.

Conclusions The majority of trauma patients have active FXIa in their plasma, with a significant fraction having active TF as well. Additionally, both TF and FXIa frequency and concentration directly relate to trauma severity. These data suggest the use of these two proteins as potential markers for the stratification of trauma patients.

Authors' Contributions

S.M.P. participated in data analysis and wrote the manuscript; M.S.P. designed the study and provided plasma samples and clinical data of the patients; K.G.M. participated in the design of the study and methodology of protein quantification and with the data analysis; S.B. participated in the design of the study and development of FXIa and TF assays, and also participated in data analysis and manuscript writing.


 
  • References

  • 1 GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 385 (9963): 117-171
  • 2 Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma 2006; 60 (6, Suppl): S3-S11
  • 3 Sauaia A, Moore FA, Moore EE. , et al. Epidemiology of trauma deaths: a reassessment. J Trauma 1995; 38 (02) 185-193
  • 4 Butenas S. Tissue factor structure and function. Scientifica (Cairo) 2012; 2012: 964862
  • 5 Butenas S, Bouchard BA, Brummel-Ziedins KE, Parhami-Seren B, Mann KG. Tissue factor activity in whole blood. Blood 2005; 105 (07) 2764-2770
  • 6 Wang P, Ba ZF, Chaudry IH. Endothelial cell dysfunction occurs very early following trauma-hemorrhage and persists despite fluid resuscitation. Am J Physiol 1993; 265 (3 Pt 2): H973-H979
  • 7 Gando S, Kameue T, Nanzaki S, Hayakawa T, Nakanishi Y. Participation of tissue factor and thrombin in posttraumatic systemic inflammatory syndrome. Crit Care Med 1997; 25 (11) 1820-1826
  • 8 Utter GH, Owings JT, Jacoby RC, Gosselin RC, Paglieroni TG. Injury induces increased monocyte expression of tissue factor: factors associated with head injury attenuate the injury-related monocyte expression of tissue factor. J Trauma 2002; 52 (06) 1071-1077 , discussion 1077
  • 9 MacFarlane RG. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 1964; 202: 498-499
  • 10 Gansler J, Jaax M, Leiting S. , et al. Structural requirements for the procoagulant activity of nucleic acids. PLoS One 2012; 7 (11) e50399
  • 11 Kannemeier C, Shibamiya A, Nakazawa F. , et al. Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc Natl Acad Sci U S A 2007; 104 (15) 6388-6393
  • 12 Müller F, Mutch NJ, Schenk WA. , et al. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 2009; 139 (06) 1143-1156
  • 13 Smith SA, Morrissey JH. Polyphosphate: a new player in the field of hemostasis. Curr Opin Hematol 2014; 21 (05) 388-394
  • 14 Wuillemin WA, Minnema M, Meijers JC. , et al. Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: major role for C1-inhibitor. Blood 1995; 85 (06) 1517-1526
  • 15 Prior SM, Cohen MJ, Conroy AS. , et al. Correlation between factor (F)XIa, FIXa and tissue factor and trauma severity. J Trauma Acute Care Surg 2017; 82 (06) 1073-1079
  • 16 Undas A, Owczarek D, Gissel M, Salapa K, Mann KG, Butenas S. Activated factor XI and tissue factor in inflammatory bowel disease. Inflamm Bowel Dis 2010; 16 (09) 1447-1448
  • 17 Butenas S, Undas A, Gissel MT, Szuldrzynski K, Zmudka K, Mann KG. Factor XIa and tissue factor activity in patients with coronary artery disease. Thromb Haemost 2008; 99 (01) 142-149
  • 18 Undas A, Slowik A, Gissel M, Mann KG, Butenas S. Circulating activated factor XI and active tissue factor as predictors of worse prognosis in patients following ischemic cerebrovascular events. Thromb Res 2011; 128 (05) e62-e66
  • 19 Ząbczyk M, Butenas S, Plicner D, Fijorek K, Sadowski J, Undas A. Factors associated with the presence of circulating active tissue factor and activated factor XI in stable angina patients. Blood Coagul Fibrinolysis 2012; 23 (03) 189-194
  • 20 Cawthern KM, van 't Veer C, Lock JB, DiLorenzo ME, Branda RF, Mann KG. Blood coagulation in hemophilia A and hemophilia C. Blood 1998; 91 (12) 4581-4592
  • 21 Higgins DL, Mann KG. The interaction of bovine factor V and factor V-derived peptides with phospholipid vesicles. J Biol Chem 1983; 258 (10) 6503-6508
  • 22 Butenas S, Dee JD, Mann KG. The function of factor XI in tissue factor-initiated thrombin generation. J Thromb Haemost 2003; 1 (10) 2103-2111
  • 23 Parhami-Seren B, Butenas S, Krudysz-Amblo J, Mann KG. Immunologic quantitation of tissue factors. J Thromb Haemost 2006; 4 (08) 1747-1755
  • 24 Butenas S, Manning C, Freeman K. Factor XIa, factor IXa and tissue factor activity in blunt trauma patients. J Thromb Haemost 2015; 13 (Suppl. 02) 569
  • 25 Hotchkiss RS, Schmieg Jr RE, Swanson PE. , et al. Rapid onset of intestinal epithelial and lymphocyte apoptotic cell death in patients with trauma and shock. Crit Care Med 2000; 28 (09) 3207-3217
  • 26 Liener UC, Knöferl MW, Sträter J. , et al. Induction of apoptosis following blunt chest trauma. Shock 2003; 20 (06) 511-516
  • 27 Semeraro F, Ammollo CT, Morrissey JH. , et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood 2011; 118 (07) 1952-1961
  • 28 Lightfoot Jr E, Horton JW, Maass DL, White DJ, McFarland RD, Lipsky PE. Major burn trauma in rats promotes cardiac and gastrointestinal apoptosis. Shock 1999; 11 (01) 29-34
  • 29 Nakanishi T, Nishi Y, Sato EF, Ishii M, Hamada T, Inoue M. Thermal injury induces thymocyte apoptosis in the rat. J Trauma 1998; 44 (01) 143-148
  • 30 Park MS, Xue A, Spears GM. , et al. Thrombin generation and procoagulant microparticle profiles after acute trauma: A prospective cohort study. J Trauma Acute Care Surg 2015; 79 (05) 726-731